Kara E. Coffey, MD

  • Assistant Professor of Pediatrics

Dr. Coffey is an Assistant Professor of Pediatrics at the University of Pittsburgh School of Medicine and is board certified in Allergy and Immunology, practicing at UPMC Children’s Hospital of Pittsburgh. She came to Pittsburgh for her pediatrics residency after graduating from Robert Wood Johnson Medical School in New Jersey. After residency completion, she worked as a General Emergency Pediatrician and as a sedation physician at Children’s for two years before fellowship training at UPMC in Allergy and Immunology. 

During fellowship, she developed a special interest in the diagnosis and management of primary immunodeficiency and immune dysregulation disorders. She worked in the laboratory of Dr. Timothy Hand focusing on mucosalimmunology; specifically, breast milk IgA and bacterial binding repertoires from donor human breast milk. 

Now as junior faculty, Coffey continues to focus her academic interests on children with immunodeficiency disorders. She is also passionate about advocacy work, particularly for universal statewide newborn screening for Severe Combined Immunodeficiency. 

When outside of work, Coffey enjoys spending time with her husband, two young sons, two rambunctious Labrador retrievers, and their aloof cat. They enjoy hiking, swimming, puzzles, and cooking.

Professional and Scientific Society Memberships

  • American Academy of Pediatrics, 2012 
  • American College of Allergy, Asthma, & Immunology, 2017 
  • American Academy of Allergy, Asthma, & Immunology, 2017 
  • Clinical Immunology Society, 2018 

Education & Training

  • BA, Biology, Boston University, 2005
  • MA, Secondary Science Education, Boston University, 2006
  • MD, Rutgers Robert Wood Johnson Medical School, 2012
  • Residency in Pediatrics, UPMC Children's Hospital of Pittsburgh, 2012-2015
  • Clinical Fellowship in Allergy/Immunology, University of Pittsburgh Medical Center, 2017-2019

Selected Publications

Burke CM, Coffey KE, Mace EM, Bostwick BL, Chinn IK, Coban-Akdemir ZH, Jhangiani SN, Lupski JR, Ortiz D, Barnum JL, Allen SW, Robertson LM, Orange JS, Chong HJ. Immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome with NK dysfunction and EBV-driven malignancy treated with stem cell transplantation.  J Allergy Clin Immunol IP; Accepted for publication July 2019. 

Coffey K, Fajt ML, Acho M, Gladwin M, Petrov AA. Successful treatment of corticosteroid-refractory hypereosinophilia with reslizumab. J Investig Allergol Clin Immunol 2019; 29(3):241-242. 

Petrov AA, Traister RS, Crespo MM, Silveira FP, Xie M, Coffey K, Ensor CR, Landsittel D, Pilewski JM. A prospective observational study of hypogammaglobulinemia in the first year after lung transplantation. Transplantation Direct 2018;4:e372; doi: 10.1097/TXD.0000000000000811. 

Schrader KA, Masciari S, Boyd N, Salamanca C, Senz J, Saunders DN, Yorida E, Maines-Bandiera S, Kaurah P, Tung N, Robson ME, Ryan PD, Olopade OI, Domchek SM, Ford J, Isaacs C, Brown P, Balmana J, Razzak AR, Miron P, Coffey K, Terry MB, John EM, Andrulis IL, Knight JA, O’Malley FP, Daly M, Bender P, kConFab Investigators, Moore R, Southey MC, Hopper JL, Garber JE, Huntsman DG. Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.  J Med Genet 2011 Jan;48(1):64-8. 

Full Publication List via NIH PubMed »